The efficacy and safety of the novel aldosterone antagonist eplerenone in children with hypertension: a randomized, double-blind, dose-response study.

Source:http://linkedlifedata.com/resource/pubmed/id/20400095

Download in:

View as

General Info

PMID
20400095